Forge Medical's VasoStat Hemostasis Device to Be Distributed by Lokai Medical

 

April 23, 2018—Forge Medical, a developer of solutions for transradial and transpedal hemostasis, announced that the company has entered into a commercialization agreement with Lokai Medical. Lokai Medical, a specialty distributor of coronary/cardiovascular and interventional devices throughout the United States, is based in Phoenix, Arizona.

Forge Medical, which is based in Bethlehem, Pennsylvania, manufactures the VasoStat hemostasis device. The VasoStat device provides an effective solution for puncture site management with rapid and patent hemostasis and optimal patient comfort, stated the company.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.